Pharma

The number of in-network behavioral health providers increased by 48% in the last three years among commercial health...

An expert industry observer said CVS Health’s move into primary care is both offensive and defensive, but perhaps more...

Medical technology startup Sibel Health recently closed a $33 million Series B funding round. It will use the funds to grow...

The proportion of pharmaceutical companies hiring for future of work related positions rose in July 2022 compared with the...

Pfizer’s own R&D efforts in sickle cell disease have fallen short, so the pharmaceutical giant is turning to M&A to...

The US Food and Drug Administration (FDA) has granted approval for a supplemental New Drug Application (sNDA) of Orion and...

Payers, providers, financial institutions and tech innovators – often known as “frenemies” – need to set aside their old...

As part of its Envision U.S. Healthcare Summit, Microsoft conducted interviews with executives at Aetna CVS Health and...

Positive data show Pentarlandir is safe and effective in patients with mild-to-moderate COVID-19

Study involved patients with locally advanced, unresectable stage 3 non-small cell lung cancer

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received expanded approval from the US Food and Drug...

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to...

The US Food and Drug Administration (FDA) has granted approval for Pfizer and Myovant Sciences’ Myfembree (relugolix 40mg,...

The increases in enrollment are likely because of changes in the economy, policy changes like Medicaid expansion in the...

Nonhuman primates will be critical to our efforts to understand the long-term effects of Covid-19. Yet scientists...